Suchergebnisse - "Enzyme Inhibitors"

PubPharm (9.098)

1

Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor

enthalten in: Endocrinology | 2024

von Morita, S. | Uraki, S. | Ariyasu, H. | +7

2

Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model

enthalten in: International immunopharmacology | 2024

von Gouveia, F. | Fonseca, C. | Silva, A. | +4

3

PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells

enthalten in: The Journal of biological chemistry | 2024

von Kohyanagi, N. | Kitamura, N. | Ikeda, S. | +3

4

Advances in synthesis and biological evaluation of CDK2 inhibitors for cancer therapy

enthalten in: Bioorganic chemistry | 2024

von Patel, D. | Patel, S. | Patel, H.

5

Resistance to PRMT5-targeted therapy in mantle cell lymphoma

enthalten in: Blood advances | 2024

von Long, M. | Koirala, S. | Sloan, S. | +21

6

Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors

enthalten in: BMC cancer | 2023

von Wang, J. | Gui, L. | Mu, Y. | +5

7

Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition

enthalten in: Molecular cell | 2023

von Wilson, G. | Vuina, K. | Sava, G. | +11

8

Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

enthalten in: Science (New York, N.Y.) | 2023

von Lv, X. | Lu, X. | Cao, J. | +36

CommentIn: Nat Rev Drug Discov. 2023 Nov;22(11):871. - PMID 37758873

9

Impact of glycogen synthase kinase-3ß inhibition on rats' temporomandibular joint collagen-induced rheumatoid arthritis with correlation to miRNA-155/miRNA-24 expression

enthalten in: European review for medical and pharmacological sciences | 2023

von Al-Serwi, R. | Othman, G. | Dawood, A. | +5

10

Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors

enthalten in: Cancer | 2023

von Pant, S. | Hamilton, E. | Ulahannan, S. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[910]